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1. Introduction 
Numerous tudies [l-4] have documented that 
cyclic AMP plays a central role in the hormonal 
regulation of cell growth and function and that its 
content in the mammary gland increases progressively 
during the growth stage of pregnancy and then, at 
parturition, decreases rapidly to the low levels seen 
during the lactational period. These findings suggest 
that cyclic AMP is a negative controlling factor for 
lactogenesis. It has also been demonstrated that 3’,5’- 
nucleotide phosphodiesterase, theenzyme which 
hydrolyses cyclic nucleotides, isactivated by cal- 
modulin, a thermostable ow M, protein already 
studied in several tissues, but not in mammary gland 
[S]. Calmodulin is an intracellular calcium receptor 
protein that binds to Ca2+ when their concentration 
increases inresponse to stimulus. This binding induces 
a distinct change in the shape of the cahnodulin mole- 
cule which in turn is capable of binding to any of 
several enzymes, activating them and so setting in 
motion the biochemical changes that produce directly 
the response to the stimulus. Calmodulin can also 
indirectly modify cell activation by affecting the con- 
centration of calcium itself and that of other impor- 
tant cellular egulators, including cyclic AMP. The 
finding that Ca*+, in cooperation with calmodulin, 
can alter cyclic nucleotides concentration i dicates 
one way by which the actions of the 2 regulatory 
agents may be integrated in regulating the lactogenic 
cycle in mammary gland. 
and its activating capacity for the enzyme, both from 
bovine brain and mammary gland, and analyse its 
kinetic properties. Our results upport he view that 
calmodulin plays a regulatory role during lactogenesis. 
2. Materials and methods 
Virgin albino rats of the Sprague-Dawley strain, 
aged -3 months (180-230 g) were used. Mated 
animals were taken at different stages of pregnancy 
and lactation. The animals were killed by decapita- 
tion and the abdominal mammary glands rapidly 
excised and homogenized at 4°C. 
Cyclic [8-3H]AMPwas obtained from New England 
Nuclear (1 mCi/ml and 32.3 Cilmmol). Crotalus at!ox 
venom 5’-nucleotidase, cyclic AMP, cyclic GMP, 
DEAE-Sephadex A-50 and DEAE-cellulose were 
purchased from Sigma (St Louis MD). All other 
reagents were from Merck (Darmstadt). 
2.1. Cyclic nucleotide phosphodiesterase purification 
The enzyme was purified both from bovine brain 
and rat lactating mammary tissue (50 g) by ammonium 
sulphate precipitation followed by DEAE-Sephadex 
A-50 chromatography according to [6]. This provided 
an enzyme preparation free from the activator cal- 
modulin. Active fractions were assayed for phospho- 
diesterase activity by two different methods. 
Here, we have analysed the involvement of cal- 
modulin in the control of the lactogenic ycle of the 
rat and its relation to cyclic nucleotide phosphodies- 
terase activity in the mammary gland. We present 
evidence for the existence of calmodulin in the gland 
2.2. @clic AMP-phosphodiesterase activity assay 
Two methods, each of 2 stages, were used to 
determine phosphodiesterase ctivity: 
Method I was a modified procedure of that in [7] in 
which Pi was determined by the method in [8] 
after its release from 5’-AMP via the action of 
snake venom 5’-nucleotidase. 
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Method II, an isotopic assay, was essentially as in 
[Il. 
The reaction mixture in each assay method contained 
40 mM Tris-HCl (pH 8 .O), 2 mM cyclic AMP (with 
which total phosphodiesterase ctivity, low and high 
Km-values, was determined) and 2 mM MnC12. The 
high Km cyclic AMP enzyme was assayed as in [ 11. 
Specific activity was expressed as pmol cyclic AMP 
hydrolyzed . mg protein-‘. min-‘. 
2.3. Calmodulin assay 
The activator protein was assayed for its ability to 
stimulate the activity of partially purified phospho- 
diesterase from bovine brain [9] and mammary gland. 
Mammary gland tissue was homogenized with 5 vol. 
20 mM Tris-HCl (PH 7 S) in an Ultra-Turrax blendor 
(Janke and Kunkel, Staufen) for 2 min. The homog- 
enate was heated in a boiling water bath for 3 min. 
Boiling inactivates phosphodiesterase butnot the 
activator. After centrifuging for 10 min at 750 X g, 
the supernatant was diluted by the addition of an 
equal volume of Tris buffer and 0.08 ml this diluted 
material was taken and added to the phosphodiesterase 
assay mixture as before. Calcium was present in this 
mixture at a tinal,concentration f 0.01 mM. The 
basal activity of the purified phosphodiesterase was 
subtracted from the total activity and the corrected 
value was defined as stimulated activity. The amount 
of protein (,ug) required to produce 50% activation 
of partially purified phosphodiesterase was defined 
as 1 unit of calmodulin. 
Proteins were determined as in [lo] using bovine 
serum albumin as a standard. 
3. Results 
Fig.1 shows the activities of partially purified 
cyclic nucleotide phosphodiesterase from lactating 
rat mammary gland in the presence of different 
amounts of activator in the crude extract also obtained 
from rat mammary gland. It is apparent that the 
activation kinetics are sigmoid, with the enzyme 
activity attaining aplateau which corresponds to 50- 
times the activity of the enzyme in the absence of 
activator. A similar pattern was obtained when the 
partially purified enzyme from bovine brain was 
activated by the extract of mammary gland contain- 
ing the activator (not shown) although the degree of 
activation was lower than with the mammary enzyme. 
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Fig.1. Activation of partially purified cyclic nucleotide phos- 
phodiesterase from lactating mammary gland by crude rat 
mammary gland activator protein (calmodulin). All values 
are in duplicate. 
Trifluoperazine, adrug which inhibits the calmo- 
dulin activation of bovine brain phosphodiesterase, 
also inhibits the effect of the activator protein on the 
mammary gland enzyme (fig2), possibly indicating 
the identity of the activator and calmodulin. 
Results in fig.3 show the activity levels for both 
activator and cyclic AMP-phosphodiesterase in rat 
mammary gland during the lactogenic ycle. It can 
be seen that the activator activity remains low, as in 
the virgin gland, until day 15 of pregnancy. Then it 
starts increasing and attains its maximum activity near 
parturition, maintaining higher levels in lactation than 
Trifluoperazine (mM) 
Fig.2. Inhibition by trifluoperazine of calmodulin mammary 
gland phosphodiesterase activation. All values are in duplicate. 
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Fig.3. Activator (calmodulin) and high Km cyclic AMP phos- 
phodiesterase activities in rat mammary gland during the 
lactogenic cycle. Results are given as the mean values f SEM; 
each value represents the mean of 5 animals: (o-o) acti- 
vator activity; (e-e) high Km cyclic AMP phosphodiester- 
ase (from [ 121). 
in pregnancy. This pattern is analogous to that for 
the high Km phosphodiesterase, an enzyme which 
starts increasing during pregnancy but presents its 
highest activity during lactation. 
Table 1 shows ome kinetic data obtained with the 
partially purified cyclic nucleotide phosphodiesterase 
from rat mammary gland with and without activator 
present. It can be seen that the activator increases the 
V max for both cyclic nucleotides, CAMP and cGMP, 
while it only increases the Km for cyclic GMP with- 
out any change in Km -value for cyclic AMP. 
4. Discussion 
Although it is not established that the activator in 
the mammary gland extracts is, in fact, calmodulin, 
Table 1 
Kinetic data for partially purified cyclic nucleotide 
phosphodiesterase from rat mammary gland with and 
without calmodulin (CaM) 
Cyclic AMP Cyclic GMP 
-CaM +CaM -CaM +CaM 
(LOO ccg) (LOO /Jg) 
Km CPM) 50 50 30 140 
h?mgprotein) 12 28 30 61 
vmaxlKm 0.2 0.6 1.0 0.4 
the mode of extraction used in the preparation of 
these extracts, the activation characteristics of the 
extracts on phosphodiesterase ctivity and the inhibi- 
tion of this activation by trifluoperazine, make it a 
reasonable assumption that these 2 substances are 
identical. Until this identity is firmly established, 
probably by the use of calmoduhn-specific antibody, 
this discussion will assume, as a working hypothesis, 
that the activator present in the mammary gland 
extracts is calmodulin. 
This study shows that cahnodulin from rat mam- 
mary gland is able to activate the cyclic nucleotide 
phosphodiesterase of the gland in a sigmoidal fashion, 
similar to that exhibited by the enzyme from bovine 
brain. The activation of both enzymes is selectively 
inhibited by 60 PM trifluoperazine, a drug which also 
inhibits the activation of brain phosphodiesterase by 
calmodulin from the same tissue. These results con- 
firm the universal action of calmodulin and its lack 
of tissue specificity [ 111. 
On studying calmodulin levels in mammary gland 
through the lactogenic ycle, the maximal level was 
achieved at parturition with the amount present 
during lactation also being higher than that present 
during pregnancy. This pattern is analogous to that 
for the high Km cyclic AMP-phosphodiesterase , an 
enzyme which starts increasing during pregnancy but 
only reaches its maximal level during lactation. This 
pattern is especially important if we consider that 
the high Km phosphodiesterase i  much more abun- 
dant than the low Km isoenzyme in mammary gland 
[ 121. Although the distribution of the activities of 
the 2 proteins, calmoduhn and phosphodiesterase, do 
not parallel one another in various other tissues of 
the rat during development, they do behave so in 
i-qlated rat parenchymal cells and in human blood 
platelets [5]. Calmodulin is active only as a calmodu- 
lin-Ca2+ complex [S ,131 and this suggests hat the 
higher activity of this modulator during lactogenesis, 
with respect o the virgin mammary gland, is due to 
the higher Ca2+ content of the lactogenic tissue. 
In spite of the many kinetic studies, in several 
laboratories [ 14-181, it is still not clear that modifi- 
cation of the kinetic parameters of phosphodiesterase 
by calmodulin plays a physiological role in cell regu- 
lation. 
The high Km phosphodiesterase has been purified 
from pig heart and bovine brain [14,17] and it has 
been demonstrated that this same nzyme exists in 
both tissues. This enzyme, which is sensitive to the 
129 
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presence of calmodulin, catalyzes the hydrolysis both 
of cyclic AMP and cyclic GMP, one nucleotide 
inhibiting competitively the hydrolysis of the other 
[14,18]. Kinetic studies with these enzyme prepara- 
tions have shown that calmodulin decreases the Km 
of the enzyme for cyclic AMP and increases V,, 
[ 151 while other authors have also found an increase 
in ‘max but without any change in Km for cyclic 
AMP as well as for cyclic GMP [ 14,191. Still others 
report an increase in V,, without change in Km 
[ 151. These discrepancies can be ascribed to the dif- 
ferent calmodubn concentrations employed by the 
different authors and to different enzyme prepara- 
tions or experimental conditions. For example, it is 
well known that, at low concentrations, cGMP acts 
as a better substrate than does CAMP while the reverse 
is observed at high substrate concentration. With our 
partially purified cyclic nucleotide phosphodiesterase 
from rat mammary gland we observed that calmodulin 
produces an increase in Pm, for both cyclic nucleo- 
tides but a Km increase only for cyclic GMP. Calmo- 
dulin increased the catalytic efficiency (I/,,/K,) of 
the enzyme for cyclic AMP and decreased that for 
cyclic GMP, suggesting a regulatory role for calmodu- 
lin in mammary gland in that it allows the predomi- 
nance of cyclic GMP over cyclic AMP during lacto- 
genesis. These results are in agreement with the phys- 
iological role attributed to both cyclic nucleotides 
during the lactogenic ycle [2-4,201 and open a new 
perspective for understanding the molecular mecha- 
nisms which control lactogenesis. 
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